Small Molecules
28 June 2016
NeuroMax Announces Start Phase 1 Clinical Trial of AQU-005 for the Treatment of Neuropathic Pain28 June 2016
Bayer’s Regorafenib Significantly Improves Overall Survival in Patients with Unresectable Liver Cancer28 June 2016
Infinity Regains Worldwide Rights To Duvelisib Following Mutual Agreement With AbbVie To End Collaboration28 June 2016
New antibiotic Zavicefta approved in the European Union for patients with serious bacterial infections27 June 2016
The Medicines Company Announces Positive Top- Line Results for Phase 3 TANGO 1 Clinical Trial of CARBAVANCE24 June 2016
City of Hope, Novonco Therapeutics Inc. Announce First-In-Human Clinical Trial for COH29News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports